In addition, there is no significant correlation between ALDH1A1 expression and the 5 clinicopathological parameters (tumor size, LNM, SBR grade, PR, and HER2) in the ≥ stage II subgroup. This evidence concerns the gene ALDH1A1 and neoplasm.